PEP A2Glob, also known as Pepsinogen A2 Globulin, is a specific biomarker of considerable interest in the field of gastroenterology and digestive health. Pepsinogen, an inactive precursor of the enzyme pepsin, plays a critical role in protein digestion within the stomach. It is secreted by the gastric chief cells and is converted to active pepsin in the acidic environment of the stomach. The A2 globulin variant of pepsinogen, or PEP A2Glob, is one of the multiple isoforms of pepsinogen. Elevated levels of PEP A2Glob can be indicative of certain gastric conditions. For instance, increased levels are often observed in patients with peptic ulcer disease, as the body may produce more pepsinogen in response to the ulceration. Conversely, significantly low levels of PEP A2Glob can be a marker for atrophic gastritis, a condition characterized by the gradual loss of gastric glandular cells, leading to reduced acid and pepsinogen production. The measurement of PEP A2Glob levels, therefore, assists in the diagnosis and monitoring of these gastric conditions. Additionally, alterations in PEP A2Glob levels have been studied in relation to gastric cancer and H. pylori infection, providing valuable insights into the pathophysiology of these conditions. The assessment of PEP A2Glob, alongside other diagnostic parameters, is essential for a comprehensive understanding of various gastrointestinal disorders and for tailoring appropriate treatment strategies.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.